Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ambrose

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 21, 2016
Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β TreatmentXiaohong Bi, Ingo Grafe, Hao Ding, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection ModelBrian D VanScoy, Michael Trang, Jennifer McCauley, et al.
Journal of the American Geriatrics Society|March 5, 2019
Factors Considered by Interprofessional Team for Treatment Decision in Hip Fracture with DementiaAlice C Baker, Catherine G Ambrose, Paula L Knudson, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaJ C Bader, E A Lakota, G E Dale, et al.
Clinical Orthopaedics and Related Research|October 17, 2015
Do Transsacral-transiliac Screws Across Uninjured Sacroiliac Joints Affect Pain and Functional Outcomes in Trauma Patients?John Heydemann, Braden Hartline, Mary Elizabeth Gibson, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhiBrent M Booker, Patrick F Smith, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection ModelBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2012
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearanceJürgen B Bulitta, Olanrewaju O Okusanya, Alan Forrest, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 21, 2016
Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β TreatmentXiaohong Bi, Ingo Grafe, Hao Ding, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection ModelBrian D VanScoy, Michael Trang, Jennifer McCauley, et al.
Journal of the American Geriatrics Society|March 5, 2019
Factors Considered by Interprofessional Team for Treatment Decision in Hip Fracture with DementiaAlice C Baker, Catherine G Ambrose, Paula L Knudson, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaJ C Bader, E A Lakota, G E Dale, et al.
Clinical Orthopaedics and Related Research|October 17, 2015
Do Transsacral-transiliac Screws Across Uninjured Sacroiliac Joints Affect Pain and Functional Outcomes in Trauma Patients?John Heydemann, Braden Hartline, Mary Elizabeth Gibson, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhiBrent M Booker, Patrick F Smith, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment <i>In Vitro</i> Infection ModelBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2012
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearanceJürgen B Bulitta, Olanrewaju O Okusanya, Alan Forrest, et al.
Pageof 25